SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is trending following news of its upcoming inclusion in the S&P MidCap 400, which is driving significant community discussion around a potential "index effect" and forced buying by institutional funds. Many anticipate substantial price appreciation, with investors highlighting the company's solid fundamentals, recent profitability, and strategic positioning in the burgeoning Agentic AI sector as key long-term growth catalysts. Despite some caution regarding recent insider selling and potential short-term pullbacks, the overall sentiment remains highly bullish for this automation leader.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is actively trending due to widespread anticipation surrounding a crucial FDA meeting for its lead drug, Sonelokimab, with the community highly optimistic about favorable regulatory guidance. This positive sentiment is further amplified by intense speculation regarding a potential acquisition by a major pharmaceutical partner, with recent insider share conversions interpreted by many as a preparatory step for a significant corporate transaction.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs. This rally is fueled by tightening global supply due to upcoming Chinese export restrictions, alongside booming industrial demand from EV batteries, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is a key trending stock as the company prepares to showcase its commercial quantum computing applications at CES 2026, suggesting potential for real-world utility and sparking significant market activity. This news has fueled bullish sentiment, with many anticipating future growth and partnerships, yet a strong contingent of skeptics continues to flag concerns about the company's valuation relative to its current revenue and historical volatility.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending amidst high volatility as its recent listing on Robinhood and integration with Coinbase's Base chain draw significant attention. The community is sharply divided, with some anticipating massive gains driven by Coinbase backing and potential short squeezes, while others express frustration over perceived 'rug pull' mechanics and significant price depreciation.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending following significant insider purchases by Apple CEO Tim Cook, a Nike board member, and another director, fueling speculation about an impending turnaround for the struggling sportswear giant. The community is actively debating whether these substantial buys signal extreme confidence in Nike's future and will trigger a technical reversal, despite ongoing concerns about China sales and tariff impacts. Many investors are now evaluating if current prices present a prime buying opportunity or if further declines are anticipated given broader market conditions.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Community discussion around Apple is intense, driven by CEO Tim Cook's recent significant purchase of Nike shares, sparking widespread speculation on his insights or potential strategic implications. Simultaneously, investors are closely watching the "revitalized" App Store antitrust lawsuit and expressing concern over the company's perceived slower pace of AI innovation compared to other tech giants.

Starfighters Space Inc

Starfighters Space Inc. (FJET), a recent aerospace IPO, is fueling intense market volatility and polarizing community discussion. Many believe its low float and high short borrow fees position it for a substantial short squeeze, while a significant portion of the community views it as a pump-and-dump due to its pre-revenue status and speculative nature.

Renaissance Capital Greenwich Funds - Renaissance IPO ETF

The Renaissance IPO ETF ($IPO) is trending amid a notable resurgence in the broader IPO market, driven by a flurry of new company and SPAC filings across diverse sectors including AI, technology, and healthcare. Investor sentiment reflects a growing "IPO wave" and renewed "listing hype" for new offerings, as market participants discuss the opportunities and risks associated with this increased activity in initial public offerings.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies (ASTI) is experiencing a significant surge in interest driven by multiple strategic teaming agreements, including collaborations for defense, drone power, and advanced space applications such as lunar missions. The community is actively debating the stock's high volatility and considerable price potential, balancing excitement for its innovative space technology with ongoing discussions around historical dilutions and a recent private placement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors.   Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.

EPZM
Epizyme Inc

Feed

News

Sentiment

Fundamentals

Info

Latest EPZM News

EPZMEpizyme Inc